Systemic Mastocytoses, Indolent
1 clinical trials · Condition
◉ Watch Systemic Mastocytoses, Indolent
| Record | Firm | Date |
|---|---|---|
| Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis (NCT06915766) | Cogent Biosciences, Inc. |
Track Systemic Mastocytoses, Indolent automatically
Every clearance here is in the API, with alerts when new ones post.